Quantcast

Posts related to ‘Vascepa’

pills

Amarin Takes on More Debt, Shares Suffer

Biopharmaceutical company Amarin Corp. PLC (NASDAQ: AMRN) announced after markets closed last night that it has received $100 million in nonequity financing from an investment fund managed by Pharmakon Advisors. ...
Read Full Story »

Amarin Becomes A January 2013 Story on FDA Uncertainty

Amarin Corporation plc (NASDAQ: AMRN) is not exactly having a good day considering that its fish oil based drug for lowering triglycerides is not going to be a known event as soon ...
Read Full Story »